AURA Live signals | Maximize Profits with Getagraph.com

SELL 157479 min ago

@ $8.31

Issued: 14 Feb 2024 @ 15:25

Return: -11.55%

Previous signal: Feb 13 - 09:30

Previous signal: Buy

Return: -2.12 %

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 16:00):

Stats
Today's Volume	96 962.00
Average Volume	203 561
Market Cap	364.14M
EPS	$0 ( 2024-05-09 )
Next earnings date	( $-0.490 ) 2024-06-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.93
ATR14	$0.0210 (0.29%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-02	Kilroy Conor	Buy	144 000	Stock Option (Right to Buy)
2024-04-02	Kilroy Conor	Buy	96 000	Common Stock
2024-04-01	Kilroy Conor	Buy	0
2024-03-15	Plavsic Mark	Sell	0	Common Stock
2024-03-15	Plavsic Mark	Sell	138 000	Stock Option (Right to Buy)

INSIDER POWER
86.58
Last 96 transactions
Buy: 15 662 380 \| Sell: 3 253 163

Volume Correlation

Long: -0.08 (neutral)

Short: 0.94 (very strong)

Signal:(65.324) Expect same movement, but be aware

Aura Biosciences, Inc. Correlation

10 Most Positive Correlations
OZEM	1
NUVO	0.85
HDSN	0.834
SHC	0.833
INRO	0.816
EHLS	0.809
BITF	0.809
RKDA	0.808
RIOT	0.806
MIRM	0.802

10 Most Negative Correlations
RFAIU	-0.992
INDH	-0.902
PSTR	-0.891
BKHA	-0.885
ERNZ	-0.873
IBAC	-0.853

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Aura Biosciences, Inc. Correlation - Currency/Commodity

-0.17
( neutral )

-0.25
( neutral )

0.00
( neutral )

0.18
( neutral )

0.21
( neutral )

Aura Biosciences, Inc. Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-1.30M (0.00 %)
EPS:	$-1.930

FY	2023
Revenue:	$0
Gross Profit:	$-1.30M (0.00 %)
EPS:	$-1.930

FY	2022
Revenue:	$0
Gross Profit:	$-1.18M (0.00 %)
EPS:	$-1.910

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$0

Financial Reports:

No articles found.

Aura Biosciences, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Aura Biosciences, Inc.

Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develops AU-011 in additional ocular oncology indications, including choroidal metastases. The company was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.

Realtime updates for Aura Biosciences, Inc. [AURA]

Upcoming Earnings Alert

Aura Biosciences, Inc. Options Data

Calls

Puts